Soichiro Morinaga

4.0k citations
162 papers · 2.4k indexed · 1 hit paper · h-index 22
Topics
Pancreatic and Hepatic Oncology Research (70 papers)Gastric Cancer Management and Outcomes (29 papers)Cancer Genomics and Diagnostics (20 papers)
Journals
The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Soichiro Morinaga

150 papers receiving 2.4k citations

Hit Papers

Adjuvant chemotherapy of S-1 versus gemcitabine for resec...20162026201920222016200400600

Peers

Soichiro Morinaga
Comparison fields: 5 of 104
  • Oncology 1.6k
  • Surgery 852
  • Pulmonary and Respiratory Medicine 810
  • Cancer Research 548
  • Epidemiology 465
Replace Koji Murono with:
Koji Murono Japan
Markus Wagner Switzerland
Hisashi Nagahara Japan
Hiroyuki Takamura Japan
M. Klimpfinger Austria
Toshiki Rikiyama Japan
Christian Partensky France
Hiroaki Tanaka Japan
Peng Gao China
Masato Nagino Japan
Soichiro Morinaga relative to Koji Murono Japan Koji Murono's profile →
Citations per field
00.5×1.5×2.3×
Koji Murono · 1×
Citations per year

Countries citing papers authored by Soichiro Morinaga

Since Specialization
Citations

This map shows the geographic impact of Soichiro Morinaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Morinaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Morinaga more than expected).

Fields of papers citing papers by Soichiro Morinaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soichiro Morinaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Morinaga. The network helps show where Soichiro Morinaga may publish in the future.

Co-authorship network of co-authors of Soichiro Morinaga

This figure shows the co-authorship network connecting the top 25 collaborators of Soichiro Morinaga. A scholar is included among the top collaborators of Soichiro Morinaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soichiro Morinaga. Soichiro Morinaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 6
4 8
5 3
6 16
7 3
8 3
9 1
10 3
11 6
12 3
13 18
14 1
15
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)breakdown →
742
16 3
17 7
18 0
19 0
20 28

About Soichiro Morinaga

Soichiro Morinaga is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 162 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (70 papers), Gastric Cancer Management and Outcomes (29 papers) and Cancer Genomics and Diagnostics (20 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (548 citations) and Pulmonary and Respiratory Medicine (810 citations). Soichiro Morinaga has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Yasushi Rino, Manabu Shiozawa, Makoto Akaike, Munetaka Masuda, Naoto Yamamoto, Katsuhiko Uesaka, Yasuhiro Shimizu, Satoshi Hirano, Masaru Konishi and Akira Fukutomi. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026